High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma

Volume 316:1493-1498		June 11, 1987		Number 24

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma

T Philip, JO Armitage, G Spitzer, F Chauvin, S Jagannath, JY Cahn, P Colombat, AH Goldstone, NC Gorin, M Flesh, and et al.

Add to Personal Archive

Add to Citation Manager

Notify a Friend

E-mail When Cited

PubMed Citation

Abstract

Adult patients with advanced non-Hodgkin's lymphoma in whom conventional chemotherapy has failed are seldom cured thereafter. We studied 100 such patients with intermediate-grade or high-grade non-Hodgkin's lymphoma who were subsequently treated with high-dose chemotherapy (61 patients) or high-dose chemotherapy plus total-body irradiation (39 patients), with bone marrow transplantation used for hematologic support. Thirty-four patients had disease that had been refractory to primary chemotherapy, and 66 patients had had a complete remission with primary chemotherapy but later relapsed. Before autologous bone marrow transplantation and high-dose chemotherapy, the 66 relapsed patients had also received conventional salvage chemotherapy; 22 had had no response or had had disease progression (a response termed "resistant relapse"), and 44 patients had responded partially or completely (a response termed "sensitive relapse"). After high-dose therapy and bone marrow transplantation, the actuarial three-year disease-free survival was zero in the refractory group, 14 percent in the resistant-relapse group, and 36 percent in the sensitive-relapse group. Patients who had had a complete remission in response to initial chemotherapy had a higher disease-free survival rate than those who had not (P less than 0.001), and patients with sensitive relapse had a higher disease-free survival rate than those with resistant relapse (P less than 0.003). These results should be considered in the planning or interpretation of trials of salvage chemotherapy in adults with non-Hodgkin's lymphoma.

This article has been cited by other articles:

Loberiza, F. R. Jr, Cannon, A. J., Weisenburger, D. D., Vose, J. M., Moehr, M. J., Bast, M. A., Bierman, P. J., Bociek, R. G., Armitage, J. O. (2009). Survival Disparities in Patients With Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study. JCO 27: 5376-5382 [Abstract] [Full Text]
Derenzini, E., Fina, M. P., Stefoni, V., Pellegrini, C., Venturini, F., Broccoli, A., Gandolfi, L., Pileri, S., Fanti, S., Lopci, E., Castellucci, P., Agostinelli, C., Baccarani, M., Zinzani, P. L. (2009). MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Ann Oncol 0: mdp455v1-mdp455 [Abstract] [Full Text]
Gisselbrecht, C., Vose, J., Nademanee, A., Gianni, A. M., Nagler, A. (2009). Radioimmunotherapy for Stem Cell Transplantation in Non-Hodgkin's Lymphoma: In Pursuit of a Complete Response. The Oncologist 14: 41-51 [Abstract] [Full Text]
RUSCITTI, C., GUADAGNI, S., RUSSO, F., PALUMBO, G., FIORENTINI, G., MAMBRINI, A., CANTORE, M., KANAVOS, E., PINTO, A., AMICUCCI, G. (2009). Thoracic Stop-flow Perfusion for Refractory Lymphoma: A Phase I-II Evaluation Trial. In Vivo 23: 447-457 [Abstract] [Full Text]
Thomson, K. J., Morris, E. C., Bloor, A., Cook, G., Milligan, D., Parker, A., Clark, F., Yung, L., Linch, D. C., Chakraverty, R., Peggs, K. S., Mackinnon, S. (2009). Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma. JCO 27: 426-432 [Abstract] [Full Text]
Wolff, S. N., Hainsworth, J. D., Greco, F. A. (2008). High-Dose Etoposide: From Phase I to a Component of Curative Therapy. JCO 26: 5310-5312 [Full Text]
Wiernik, P. H., Lossos, I. S., Tuscano, J. M., Justice, G., Vose, J. M., Cole, C. E., Lam, W., McBride, K., Wride, K., Pietronigro, D., Takeshita, K., Ervin-Haynes, A., Zeldis, J. B., Habermann, T. M. (2008). Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma. JCO 26: 4952-4957 [Abstract] [Full Text]
Hosing, C., Saliba, R. M., Okoroji, G.-J., Popat, U., Couriel, D., Ali, T., De Padua Silva, L., Kebriaei, P., Alousi, A., De Lima, M., Qazilbash, M., Anderlini, P., Giralt, S., Champlin, R. E., Khouri, I. (2008). High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age. Ann Oncol 19: 1166-1171 [Abstract] [Full Text]
Thompson, J. A., Fisher, R. I., LeBlanc, M., Forman, S. J., Press, O. W., Unger, J. M., Nademanee, A. P., Stiff, P. J., Petersdorf, S. H., Fefer, A. (2008). Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438). Blood 111: 4048-4054 [Abstract] [Full Text]
Hoppe, B. S., Moskowitz, C. H., Filippa, D. A., Moskowitz, C. S., Kewalramani, T., Zelenetz, A. D., Yahalom, J. (2008). Involved-Field Radiotherapy Before High-Dose Therapy and Autologous Stem-Cell Rescue in Diffuse Large-Cell Lymphoma: Long-Term Disease Control and Toxicity. JCO 26: 1858-1864 [Abstract] [Full Text]
Vellenga, E., van Putten, W. L. J., van 't Veer, M. B., Zijlstra, J. M., Fibbe, W. E., van Oers, M. H. J., Verdonck, L. F., Wijermans, P. W., van Imhoff, G. W., Lugtenburg, P. J., Huijgens, P. C. (2008). Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial. Blood 111: 537-543 [Abstract] [Full Text]
Moskowitz, C. H., Hamlin, P. A., Gabrilove, J., Bertino, J. R., Portlock, C. S., Straus, D. J., Gencarelli, A. N., Nimer, S. D., Zelenetz, A. D. (2007). Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma. Ann Oncol 18: 1842-1850 [Abstract] [Full Text]
Armitage, J. O. (2007). How I treat patients with diffuse large B-cell lymphoma. Blood 110: 29-36 [Full Text]
Rohatiner, A. Z.S., Nadler, L., Davies, A. J., Apostolidis, J., Neuberg, D., Matthews, J., Gribben, J. G., Mauch, P. M., Lister, T. A., Freedman, A. S. (2007). Myeloablative Therapy With Autologous Bone Marrow Transplantation for Follicular Lymphoma at the Time of Second or Subsequent Remission: Long-Term Follow-Up. JCO 25: 2554-2559 [Abstract] [Full Text]
Wannesson, L, Panzarella, T, Mikhael, J, Keating, A (2007). Feasibility and safety of autotransplants with noncryopreserved marrow or peripheral blood stem cells: a systematic review. Ann Oncol 18: 623-632 [Abstract] [Full Text]
Habermann, T. M. (2007). Antibody Therapy in Aggressive Lymphomas. ASH Education Book 2007: 257-264 [Abstract] [Full Text]
Copelan, E. A. (2006). Hematopoietic stem-cell transplantation.. NEJM 354: 1813-1826 [Full Text]
Olivieri, A., Santini, G., Patti, C., Chisesi, T., De Souza, C., Rubagotti, A., Aversa, S., Billio, A., Porcellini, A., Candela, M., Centurioni, R., Congiu, A. M., Brunori, M., Nati, S., Spriano, M., Vimercati, R., Marino, G., Contu, A., Tedeschi, L., Majolino, I., Crugnola, M., Sertoli, M. R. (2005). Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG. Ann Oncol 16: 1941-1948 [Abstract] [Full Text]
Bhatia, R., Van Heijzen, K., Palmer, A., Komiya, A., Slovak, M. L., Chang, K. L., Fung, H., Krishnan, A., Molina, A., Nademanee, A., O'Donnell, M., Popplewell, L., Rodriguez, R., Forman, S. J., Bhatia, S. (2005). Longitudinal Assessment of Hematopoietic Abnormalities After Autologous Hematopoietic Cell Transplantation for Lymphoma. JCO 23: 6699-6711 [Abstract] [Full Text]
Vose, J. M., Bierman, P. J., Enke, C., Hankins, J., Bociek, G., Lynch, J. C., Armitage, J. O. (2005). Phase I Trial of Iodine-131 Tositumomab With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Relapsed Non-Hodgkin's Lymphoma. JCO 23: 461-467 [Abstract] [Full Text]
Morris, E., Thomson, K., Craddock, C., Mahendra, P., Milligan, D., Cook, G., Smith, G. M., Parker, A., Schey, S., Chopra, R., Hatton, C., Tighe, J., Hunter, A., Peggs, K., Linch, D., Goldstone, A., Mackinnon, S. (2004). Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood 104: 3865-3871 [Abstract] [Full Text]
Rodriguez, J., Caballero, M. D., Gutierrez, A., Solano, C., Arranz, R., Lahuerta, J. J., Sierra, J., Gandarillas, M., Perez-Simon, J. A., Zuazu, J., Lopez-Guillermo, A., Sureda, A., Carreras, E., Garcia-Larana, J., Marin, J., Garcia, J. C., Fernandez de Sevilla, A., Rifon, J., Varela, R., Jarque, I., Albo, C., Leon, A., SanMiguel, J., Conde, E. (2004). Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience. Ann Oncol 15: 1504-1509 [Abstract] [Full Text]
Kewalramani, T., Zelenetz, A. D., Nimer, S. D., Portlock, C., Straus, D., Noy, A., O'Connor, O., Filippa, D. A., Teruya-Feldstein, J., Gencarelli, A., Qin, J., Waxman, A., Yahalom, J., Moskowitz, C. H. (2004). Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood 103: 3684-3688 [Abstract] [Full Text]
Corradini, P., Ladetto, M., Zallio, F., Astolfi, M., Rizzo, E., Sametti, S., Cuttica, A., Rosato, R., Farina, L., Boccadoro, M., Benedetti, F., Pileri, A., Tarella, C. (2004). Long-Term Follow-Up of Indolent Lymphoma Patients Treated With High-Dose Sequential Chemotherapy and Autografting: Evidence That Durable Molecular and Clinical Remission Frequently Can Be Attained Only in Follicular Subtypes. JCO 22: 1460-1468 [Abstract] [Full Text]
Rodriguez, J., Caballero, M. D., Gutierrez, A., Marin, J., Lahuerta, J. J., Sureda, A., Carreras, E., Leon, A., Arranz, R., Fernandez de Sevilla, A., Zuazu, J., Garcia-Larana, J., Rifon, J., Varela, R., Gandarillas, M., SanMiguel, J., Conde, E. (2003). High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience. Ann Oncol 14: 1768-1775 [Abstract] [Full Text]
Hamlin, P. A., Zelenetz, A. D., Kewalramani, T., Qin, J., Satagopan, J. M., Verbel, D., Noy, A., Portlock, C. S., Straus, D. J., Yahalom, J., Nimer, S. D., Moskowitz, C. H. (2003). Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. Blood 102: 1989-1996 [Abstract] [Full Text]
Filmont, J.-E., Czernin, J., Yap, C., Silverman, D. H. S., Quon, A., Phelps, M. E., Emmanouilides, C. (2003). Value of F-18 Fluorodeoxyglucose Positron Emission Tomography for Predicting the Clinical Outcome of Patients With Aggressive Lymphoma Prior to and After Autologous Stem-Cell Transplantation. Chest 124: 608-613 [Abstract] [Full Text]
Martelli, M., Gherlinzoni, F., De Renzo, A., Zinzani, P. L., De Vivo, A., Cantonetti, M., Falini, B., Storti, S., Meloni, G., Rizzo, M., Molinari, A. L., Lauria, F., Moretti, L., Lauta, V. M., Mazza, P., Guardigni, L., Pescarmona, E., Pileri, S.A., Mandelli, F., Tura, S. (2003). Early Autologous Stem-Cell Transplantation Versus Conventional Chemotherapy as Front-Line Therapy in High-Risk, Aggressive Non-Hodgkin's Lymphoma: An Italian Multicenter Randomized Trial. JCO 21: 1255-1262 [Abstract] [Full Text]
Caballero, M. D., Perez-Simon, J. A., Iriondo, A., Lahuerta, J. J., Sierra, J., Marin, J., Gandarillas, M., Arranz, R., Zuazu, J., Rubio, V., Fernandez de Sevilla, A., Carreras, E., Garcia-Conde, J., Garcia-Larana, J., Grande, C., Sureda, A., Vidal, M. J., Rifon, J., Perez-Equiza, C., Varela, R., Moraleda, J. M., Garcia Ruiz, J. C., Albo, C., Cabrera, R., San Miguel, J. F., Conde, E. (2003). High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Ann Oncol 14: 140-151 [Abstract] [Full Text]
Robertson, M. J., Pelloso, D., Abonour, R., Hromas, R. A., Nelson, R. P. Jr., Wood, L., Cornetta, K. (2002). Interleukin 12 Immunotherapy after Autologous Stem Cell Transplantation for Hematological Malignancies. Clin. Cancer Res. 8: 3383-3393 [Abstract] [Full Text]
Bertz, H., Illerhaus,, G., Veelken, H., Finke, J. (2002). Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens. Ann Oncol 13: 135-139 [Abstract] [Full Text]
Rodriguez, J., Munsell, M., Yazji, S., Hagemeister, F. B., Younes, A., Andersson, B., Giralt, S., Gajewski, J., de Lima, M., Couriel, D., Romaguera, J., Cabanillas, F. F., Champlin, R. E., Khouri, I. F. (2001). Impact of High-Dose Chemotherapy on Peripheral T-Cell Lymphomas. JCO 19: 3766-3770 [Abstract] [Full Text]
Mink, S. A., Armitage, J. O. (2001). High-Dose Therapy in Lymphomas: A Review of the Current Status of Allogeneic and Autologous Stem Cell Transplantation in Hodgkin's Disease and Non-Hodgkin's Lymphoma. The Oncologist 6: 247-256 [Abstract] [Full Text]
Kobrinsky, N. L., Sposto, R., Shah, N. R., Anderson, J. R., DeLaat, C., Morse, M., Warkentin, P., Gilchrist, G. S., Cohen, M. D., Shina, D., Meadows, A. T. (2001). Outcomes of Treatment of Children and Adolescents With Recurrent Non-Hodgkin's Lymphoma and Hodgkin's Disease With Dexamethasone, Etoposide, Cisplatin, Cytarabine, and L-Asparaginase, Maintenance Chemotherapy, and Transplantation: Children's Cancer Group Study CCG-5912. JCO 19: 2390-2396 [Abstract] [Full Text]
Williams, C. D., Harrison, C. N., Lister, T. A., Norton, A. J., Blystad, A. K., Coiffier, B., Taghipour, G., Schmitz, N., Goldstone, A. H. (2001). High-Dose Therapy and Autologous Stem-Cell Support for Chemosensitive Transformed Low-Grade Follicular Non-Hodgkin's Lymphoma: A Case-Matched Study From the European Bone Marrow Transplant Registry. JCO 19: 727-735 [Abstract] [Full Text]
Vose, J. M., Zhang, M.-J., Rowlings, P. A., Lazarus, H. M., Bolwell, B. J., Freytes, C. O., Pavlovsky, S., Keating, A., Yanes, B., van Besien, K., Armitage, J. O., Horowitz, M. M. (2001). Autologous Transplantation for Diffuse Aggressive Non-Hodgkin's Lymphoma in Patients Never Achieving Remission: A Report from the Autologous Blood and Marrow Transplant Registry. JCO 19: 406-413 [Abstract] [Full Text]
Horning, S. J., Negrin, R. S., Hoppe, R. T., Rosenberg, S. A., Chao, N. J., Long, G. D., Brown, B. W., Blume, K. G. (2001). High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. Blood 97: 404-409 [Abstract] [Full Text]
Kluin-Nelemans, H. C., Zagonel, V., Anastasopoulou, A., Bron, D., Roozendaal, K. J., Noordijk, E. M., Musson, H., Teodorovic, I., Maes, B., Carbone, A., Carde, P., Thomas, J. (2001). Standard Chemotherapy With or Without High-Dose Chemotherapy for Aggressive Non-Hodgkin's Lymphoma: Randomized Phase III EORTC Study. JNCI J Natl Cancer Inst 93: 22-30 [Abstract] [Full Text]
Kewalramani, T., Zelenetz, A. D., Hedrick, E. E., Donnelly, G. B., Hunte, S., Priovolos, A. C., Qin, J., Lyons, N. C., Yahalom, J., Nimer, S. D., Moskowitz, C. H. (2000). High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis. Blood 96: 2399-2404 [Abstract] [Full Text]
Kaminski, M. S., Estes, J., Zasadny, K. R., Francis, I. R., Ross, C. W., Tuck, M., Regan, D., Fisher, S., Gutierrez, J., Kroll, S., Stagg, R., Tidmarsh, G., Wahl, R. L. (2000). Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience. Blood 96: 1259-1266 [Abstract] [Full Text]
Krishnan, A., Bhatia, S., Slovak, M. L., Arber, D. A., Niland, J. C., Nademanee, A., Fung, H., Bhatia, R., Kashyap, A., Molina, A., O'Donnell, M. R., Parker, P. A., Sniecinski, I., Snyder, D. S., Spielberger, R., Stein, A., Forman, S. J. (2000). Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood 95: 1588-1593 [Abstract] [Full Text]
Moskowitz, C. H., Bertino, J. R., Glassman, J. R., Hedrick, E. E., Hunte, S., Coady-Lyons, N., Agus, D. B., Goy, A., Jurcic, J., Noy, A., O'Brien, J., Portlock, C. S., Straus, D. S., Childs, B., Frank, R., Yahalom, J., Filippa, D., Louie, D., Nimer, S. D., Zelenetz, A. D. (1999). Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma. JCO 17: 3776-3785 [Abstract] [Full Text]
Grossbard, M. L., Multani, P. S., Freedman, A. S., O'Day, S., Gribben, J. G., Rhuda, C., Neuberg, D., Nadler, L. M. (1999). A Phase II Study of Adjuvant Therapy with Anti-B4-blocked Ricin after Autologous Bone Marrow Transplantation for Patients with Relapsed B-Cell Non-Hodgkin's Lymphoma. Clin. Cancer Res. 5: 2392-2398 [Abstract] [Full Text]
Shipp, M.A., Abeloff, M.D., Antman, K.H., Carroll, G., Hagenbeek, A., Loeffler, M., Montserrat, E., Radford, J.A., Salles, G., Schmitz, N., Symann, M., Armitage, J.O., Philip, T., Coiffier, B. (1999). International Consensus Conference on High-Dose Therapy With Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report of the Jury. JCO 17: 423-423 [Full Text]
Mounter, P J, Lennard, A L (1999). Classic diseases revisited: Management of non-Hodgkin's lymphomas. Postgrad. Med. J. 75: 2-6 [Abstract] [Full Text]
Blay, J.-Y., Gomez, F., Sebban, C., Bachelot, T., Biron, P., Guglielmi, C., Hagenbeek, A., Somers, R., Chauvin, F., Philip, T. (1998). The International Prognostic Index Correlates to Survival in Patients With Aggressive Lymphoma in Relapse: Analysis of the PARMA Trial. Blood 92: 3562-3568 [Abstract] [Full Text]
Sehn, L. H., Antin, J. H., Shulman, L. N., Mauch, P., Elias, A., Kadin, M. E., Wheeler, C. (1998). Primary Diffuse Large B-Cell Lymphoma of the Mediastinum: Outcome Following High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation. Blood 91: 717-723 [Abstract] [Full Text]
Ladenstein, R., Pearce, R., Hartmann, O., Patte, C., Goldstone, T., Philip, T. (1997). High-Dose Chemotherapy With Autologous Bone Marrow Rescue in Children With Poor-Risk Burkitt's Lymphoma: A Report From the European Lymphoma Bone Marrow Transplantation Registry. Blood 90: 2921-2930 [Abstract] [Full Text]
Makatsoris, T., Seiden, M. V. (1997). High-Dose Therapy for Ovarian Carcinoma. The Oncologist 2: 330-339 [Abstract] [Full Text]
Gianni, A. M., Bregni, M., Siena, S., Brambilla, C., Di Nicola, M., Lombardi, F., Gandola, L., Tarella, C., Pileri, A., Ravagnani, F., Valagussa, P., Bonadonna, G. (1997). High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma. NEJM 336: 1290-1298 [Abstract] [Full Text]
Corradini, P., Astolfi, M., Cherasco, C., Ladetto, M., Voena, C., Caracciolo, D., Pileri, A., Tarella, C. (1997). Molecular Monitoring of Minimal Residual Disease in Follicular and Mantle Cell Non-Hodgkin's Lymphomas Treated With High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Autografting. Blood 89: 724-491 [Abstract] [Full Text]
Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.-Y., Harousseau, J.-L., Coiffier, B., Biron, P., Mandelli, F., Chauvin, F. (1995). Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma. NEJM 333: 1540-1545 [Abstract] [Full Text]
Verdonck, L. F., van Putten, W. L.J., Hagenbeek, A., Schouten, H. C., Sonneveld, P., van Imhoff, G. W., Kluin-Nelemans, H. C., Raemaekers, J. M.M., van Oers, R. H.J., Haak, H. L., Schots, R., Dekker, A. W., de Gast, G. C., Lowenberg, B. (1995). Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma. NEJM 332: 1045-1051 [Abstract] [Full Text]
Armitage, J. O. (1994). Bone Marrow Transplantation. NEJM 330: 827-838 [Full Text]
Cannistra, S. A. (1993). Cancer of the Ovary. NEJM 329: 1550-1559 [Full Text]
Armitage, J. O. (1993). Treatment of Non-Hodgkin's Lymphoma. NEJM 328: 1023-1030 [Full Text]
Gulati, S. C., Bennett, C. L. (1992). Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as Adjunct Therapy in Relapsed Hodgkin Disease. ANN INTERN MED 116: 177-182 [Abstract]
Advani, R., Chao, N. J., Horning, S. J., Blume, K. G., Ahn, D. K., Lamborn, K. R., Fleming, N. C., Bonnern, E. M., Greenberg, P. L. (1992). Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as an Adjunct to Autologous Hemopoietic Stem Cell Transplantation for Lymphoma. ANN INTERN MED 116: 183-189 [Abstract]
Vose, J. M., Bierman, P. J., Armitage, J. O. (1992). Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF): Answers or More Questions?. ANN INTERN MED 116: 261-262 [Abstract]
Surbone, A., Armitage, J. O., Gale, R. P. (1991). Autotransplantation in Lymphoma: Better Therapy or Healthier Patients?. ANN INTERN MED 114: 1059-1060 [Abstract]
Cheson, B. D., Lacerna, L., Leyland-Jones, B., Sarosy, G., Wittes, R. E. (1989). Autologous Bone Marrow Transplantation: Current Status and Future Directions. ANN INTERN MED 110: 51-65 [Abstract]

Comments and questions? Please contact us.